Small foci of spongy change, often bilaterally symmetric, were observed in the brains of mice exposed to benzidine dihydrochloride. These vacuoles were most frequent in the superior thalamic radiation of the internal capsule. They possibly represent swollen glial cells and intramyelinic vacuoles. N o consistent relationship was observed between the presence of vacuoles in the brain and hepatic lesions in these mice, and this change may b e attributable to benzidine treatment unrelated to toxic effects of the liver.
I NTRO D UCTI o N
Benzidine dihydrochloride induces severe liver lesions in a number of animal species and is a potent hepatocarcinogen in the mouse (1-4). Hepatic' damage has been associated with a number of neurologic disturbances and central nervous system lesions (5), but lesions of the central nervous system have not been reported in animals treated with benzidine. This report describes a spongy transformation of the white matter in the brains of mice given benzidine dihydrochloride.
MATERIALS A N D METHODS
The study included 2,592 F1 (C57BL/ 6JfC3Hf/Nctr females X BALB/cStCrlfC3H/ Nctr males) and F2 (FI males x F1 females) mice, equally divided between crosses and sex. Weanling mice (21 days of age) were housed 4 per cage in a room maintained at 22-24O C and 55 zk 10% relative humidity. Food (Purina 5010C) and water were provided ad libitum. The water contained 0, 20, 30, 40, 60, I Received October 23,1980. 80,120, or 160 ppm of benzidine dihydrochloride. Mice were examined as they became moribund or died, At death or sacrifice, each animal was assigned a carcass identification (CID) number and a detailed necropsy was performed. Gross and microscopic findings were collected as described previously (6, 7) on approximately 45 tissues or organs and on grossly visible lesions not included with these organs. The tissues were fixed in Bouin's solution for 18-24 hours. Blocks of brain were cut transversely through the cerebrum at the level of the hippocampus and midway anterio-posteriorly through the cerebellum.
After fixation the tissues were trimmed, placed in plastic cassettes for processing in an Autotechnicon on a %hour cycle and embedded in paraffin. Sections were cut at 5 pm and stained in an automatic stainer with hematoxylin and eosin (H & E). Selected sections were also stained with Luxol fast blue (LFB) for myelin.
Slides were evaluated by a pathologist having no prior knowledge of allocation to treatment groups, but the slides were not randomized. The focal areas of spongy change were scbred for severity as follows: + = minimal change; ++ = moderate change; and +++ = severe change. White matter tracts were identified in an atlas of the mouse brain and spinal cord (8) .
RESULTS
In paraffin sections focal clusters or scattered individual vacuoles were observed in, or adjacent to, the internal capsule ( Figure 1 ) involving principally the superior thalamic radiation. In a smaller proportion of cases the medial lemniscus was involved and in one case the trigeminal lemniscus was affected.
The vacuoles were spherical or oval ( Figure  2) , with an indistinct limiting membrane, and were often subdivided by delicate, LFB positive membranes (Figure 3) . The majority of vacuoles were in a "beaded" arrangement running parallel to fascicles of large myelinated axons (Figure 4 ). Some vacuoles were apparently derived from severely edematous glial cells ( Figure 5 ). The vacuoles were empty or appeared to have contained fluid, and there was no evidence of an inflammatory response. Alzheimer Type I1 glia were not observed.
The frequency of vacuolation and the scores applied are presented in Table I . This table demonstrates that the vacuoles were usually confined to treated animals. There is an apparent dose response for frequency of the lesion in the treatment groups up to 60 ppm; this leveled at about 15% in the treated
FIG. 2-Round and oval clear vacuoles lie between bundles of darkly staining myelinated axons. LFB X 150.
mice up to 60 ppm and the higher dose groups had a variable percentage affected. In 40 to 72% of affected animals the lesion was bilaterally symmetric ( Table 1 ). The brain section was cut obliquely in many of the cases in which the lesion appeared to be unilateral, and they may thus actually have been bilateral. In the majority of cases the change was minimal (Table 1) and there was no apparent dose response for severity of this lesion. There was no significant difference between strains or sexes. The average age of the mice with vacuolization decreased as the dose level of benzidine increased and the minimum age of occurrence also decreased with dose (Table   Since spongy change in the brain has been associated with liver disease, and benzidine is a hepatocarcinogen in the mouse, we made an attempt to correlate liver lesions with CNS lesions. Of the mice with the spongy change in the brain, 67.3% had some type of liver lesion, including inflammation, neoplasia or cytologic alterations. However, almost 65% of animals on the study had liver lesions, which suggests that the association between liver and brain might be a purely random event.
DISCUSSION
Spongy change in the brains of mice may be attributable to a variety of entities including processing or handling artifacts (9). In mouse brain sections at the NCTR, artifactual vacuolation is commonly observed in the cerebellum while the cerebrum is usually free of this change. We believe this difference may be due to the technique used for brain removal. The fact that the spongy change described in the present study has not been observed in other studies conducted under similar conditions at NCTR, that the lesion was bilaterally symmetric in many animals and extremely rare in the controls, is good evidence in support of this being a treatment effect and not an artifact. This type of lesion may be very easily missed, and similar lesions in the cerebellum would probably go unnoticed at NCTR. This further emphasizes the importance of careful handling of the brain and the necessity for very detailed examination of slides in toxicology studies since subtle lesions may be missed.
Although a dose-response was not entirely evident, the data did indicate that the vacuolation was probably dose related. Since this was a life-span study, there were no clear-cut age demarcations by which to judge the effects of age on the lack of a dose-response above 60 ppm. However, Table I1 presents data to show the mean age of mice with CNS vacuolation at time of death. The mean age of the control group was 1012 days with a standard deviation of 30 days and a minimum age of 978 days. By comparison, the average age of the next oldest group is 789 days with a standard deviation of 131 days and a minimum of 538 days. The average age decreased as the dose level increased while the minimum age of occurrence also decreased with increasing dose. Although not conclusive, it would appear that incidence of the CNS vacuolation may be reduced in the higher doses simply due to decreased lifespan of these animals. This would be particularly true if the vacuolation was shown to occur in the later ages of the test animal. Those showing vacuolation are older than the mean of the total and the minimum age in all cases is greater in the positive animals, indicating it is a lesion occurring in the older mice. This study was confined to light microscopic examination which prevented establishment of the nature of the vacuoles in these mouse brains. The location however was very specific and they appeared to involve glial cell cytoplasm and possibly myelin sheaths of larger axons. Apart from location this vacuolation resembled that seen in the brains of copper poisoned sheep by one of the authors (10). The latter changes are known to involve intramyelinic edema with splitting at the intraperoid line and it was proposed by these workers that this myelinopathy may be attributable to hepatic damage (10). Hepatic lesions may be associated with spongy change induced in the brains of mice by Cuprizone (11). As benzidine does cause liver damage, the change observed. in the present study may represent another case of hepatic encephalopat h y.
There was, however, no consistent relationship between hepatic damage and the spongy change and approximately one third of affected animals had no apparent liver lesions. Furthermore, in many animals with severe liver lesions the brain lesion was not detected. Hepatic encephalopathy is often associated with the presence of large, abnormal Alzeimer Type I1 glia in affected areas in man (5) and this has been reported in animals (11,lZ). We did not detect this change and thus the lesions observed may be attributable to a direct effect of benzidine, or indirectly via mechanisms other than liver damage.
The high specificity of the location of the brain lesion suggests an increased susceptibility of this area. Biochemical differences between various regions of the brain may account for lesion distribution (13). This may be a useful avenue of investigation when attempting to establish the mechanisms responsible for this lesion.
